Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial
Michael S. Niederman*, Jeff Alder, Matteo Bassetti, Francis Boateng, Bin Cao, Kevin Corkery, Rajiv Dhand, Keith S. Kaye, Robert Lawatscheck, Patrick McLeroth, David P. Nicolau, Chen Wang, G. Christopher Wood, Richard G. Wunderink, Jean Chastre
Dive into the research topics of 'Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial'. Together they form a unique fingerprint.